Cart summary

You have no items in your shopping cart.

Ranitidine bismuth citrate

SKU: orb1738421

Description

Ranitidine bismuth citrate is an oral H2-receptor antagonist used as an anti-Helicobacter pylori agent (MIC 90: 16 ng/L). Research indicates it also potently inhibits SARS-CoV-2 in vitro (IC 50: 3.3 µM), showing selectivity for infected cells, which supports its investigation in antiviral studies.

Research Area

Immunology & Inflammation, Infectious Disease & Virology, Neuroscience, Pharmacology & Drug Discovery

Images & Validation

Key Properties

CAS Number128345-62-0
MW712.48
FormulaC19H27BiN4O10S
SMILESO=C(O)CC(O)(C(=O)O)CC(=O)O.O=N(=O)C=C(NC)NCCSCC=1OC(=CC1)CN(C)C.[BiH3]
TargetSARS-CoV,Others,Antibacterial,Histamine Receptor

Storage & Handling

Storage-20°C
Expiration Date12 months from date of receipt.
DisclaimerFor research use only
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at support@biorbyt.com.

Key Properties

No computed properties available.

Documents Download

Datasheet
Product Information
Download

Request a Document

Protocol Information

Ranitidine bismuth citrate (orb1738421)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet

Step 1: Enter information below

(Recommended: An additional animal making an allowance for loss during the experiment)

Step 2: Enter the in vivo formulation

(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO +
%+
% Tween 80 +
%